| __timestamp | Ionis Pharmaceuticals, Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 19928000 |
| Thursday, January 1, 2015 | 37173000 | 30842000 |
| Friday, January 1, 2016 | 48616000 | 46527000 |
| Sunday, January 1, 2017 | 108488000 | 34451000 |
| Monday, January 1, 2018 | 244622000 | 34409000 |
| Tuesday, January 1, 2019 | 287000000 | 34417000 |
| Wednesday, January 1, 2020 | 354000000 | 145290000 |
| Friday, January 1, 2021 | 186000000 | 298358000 |
| Saturday, January 1, 2022 | 151000000 | 488691000 |
| Sunday, January 1, 2023 | 232600000 | 468946000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Ionis Pharmaceuticals and Novavax from 2014 to 2023. Ionis Pharmaceuticals saw a significant rise in SG&A expenses, peaking in 2020 with a 1,660% increase from 2014. Meanwhile, Novavax's expenses surged dramatically, especially from 2020 onwards, reflecting a 2,250% increase by 2022. This trend highlights the strategic investments both companies are making in their operations and market presence. Notably, Novavax's expenses in 2022 were nearly double those of Ionis, indicating a robust expansion phase. These insights provide a window into the financial strategies of these biotech giants, offering investors and industry watchers a glimpse into their operational priorities.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Novavax, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Novavax, Inc.
Breaking Down SG&A Expenses: MorphoSys AG vs Novavax, Inc.
Mesoblast Limited vs Novavax, Inc.: SG&A Expense Trends
Wave Life Sciences Ltd. and Novavax, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Dynavax Technologies Corporation and Novavax, Inc.